TG Therapeutics Inc
NASDAQ:TGTX

Watchlist Manager
TG Therapeutics Inc Logo
TG Therapeutics Inc
NASDAQ:TGTX
Watchlist
Price: 36.56 USD 1.5% Market Closed
Market Cap: 5.8B USD
Have any thoughts about
TG Therapeutics Inc?
Write Note

Wall Street
Price Targets

TGTX Price Targets Summary
TG Therapeutics Inc

Wall Street analysts forecast TGTX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TGTX is 43.35 USD with a low forecast of 11.11 USD and a high forecast of 57.75 USD.

Lowest
Price Target
11.11 USD
70% Downside
Average
Price Target
43.35 USD
19% Upside
Highest
Price Target
57.75 USD
58% Upside
TG Therapeutics Inc Competitors:
Price Targets
ORGO
Organogenesis Holdings Inc
91% Upside
4BB
4Basebio PLC
76% Upside
INCY
Incyte Corp
15% Upside
302440
SK Bioscience Co Ltd
21% Downside
OCX
OncoCyte Corp
75% Upside
INSM
Insmed Inc
8% Upside
LEGN
Legend Biotech Corp
133% Upside
TWST
Twist Bioscience Corp
48% Upside

Revenue
Forecast

Revenue Estimate
TG Therapeutics Inc

For the last 8 years the compound annual growth rate for TG Therapeutics Inc's revenue is 161%. The projected CAGR for the next 3 years is 48%.

161%
Past Growth
48%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
TG Therapeutics Inc

The compound annual growth rate of TG Therapeutics Inc's operating income for the next 3 years is 128%.

N/A
Past Growth
128%
Estimated Growth
Estimates Accuracy
7%
Average Beat

Net Income
Forecast

Net Income Estimate
TG Therapeutics Inc

The compound annual growth rate of TG Therapeutics Inc's net income for the next 3 years is 154%.

N/A
Past Growth
154%
Estimated Growth
Estimates Accuracy
-24%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TGTX's stock price target?
Price Target
43.35 USD

According to Wall Street analysts, the average 1-year price target for TGTX is 43.35 USD with a low forecast of 11.11 USD and a high forecast of 57.75 USD.

What is TG Therapeutics Inc's Revenue forecast?
Projected CAGR
48%

For the last 8 years the compound annual growth rate for TG Therapeutics Inc's revenue is 161%. The projected CAGR for the next 3 years is 48%.

What is TG Therapeutics Inc's Operating Income forecast?
Projected CAGR
128%

The compound annual growth rate of TG Therapeutics Inc's operating income for the next 3 years is 128%.

What is TG Therapeutics Inc's Net Income forecast?
Projected CAGR
154%

The compound annual growth rate of TG Therapeutics Inc's net income for the next 3 years is 154%.

Back to Top